Soluble adenylyl cyclase

Soluble adenylyl cyclase (sAC) is a regulatory cytosolic enzyme present in almost every cell. sAC is a source of cyclic adenosine 3’,5’ monophosphate (cAMP) – a second messenger that mediates cell growth and differentiation in organisms from bacteria to higher eukaryotes. sAC differentiates from the transmembrane adenylyl cyclase (tmACs) – an important source of cAMP; in that sAC is regulated by bicarbonate anions and it is dispersed throughout the cell cytoplasm. sAC has been found to have various functions in physiological systems different from that of the tmACs.

Genomic context and summary

sAC is encoded in a single Homo sapiens gene identified as ADCY10 or Adenylate cyclase 10 (soluble). This gene packed down 33 exons that comprise greater than 100kb; though, it seems to utilize multiple promoters,[1][2] and its mRNA undergoes extensive alternative splicing.[1][2][3][4]

Structure

The functional mammalian sAC consist of two heterologous catalytic domains (C1 and C2), forming the 50 kDa amino terminus of the protein.[5][6] The additional ~140 kDa C terminus of the enzyme includes an autoinhibitory region,[7] canonical P-loop, potential heme-binding domain,[8] and leucine zipper-like sequence,[9] which are a form of putative regulatory domains.

A truncated form of the enzyme only includes the C1 and C2 domains and it is refers to as the minimal functional sAC variant.[4][9] This sAC-truncated form has cAMP-forming activity much higher than its full-length type. These sAC variants are stimulated by HCO3- and respond to all known selective sAC inhibitors.[5] Crystal structures of this sAC variant comprising only the catalytic core, in apo form and in as complex with various substrate analogs, products, and regulators, reveal a generic Class III AC architecture with sAC-specific features.[10] The structurally related domains C1 and C2 form the typical pseudo-heterodimer, with one active site.[5] The pseudo-symmetric site accommodates the sAC-specific activator HCO3−, which activates by triggering a rearrangement of Arg176, a residue connecting both sites. The anionic sAC inhibitor 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) acts as a blocker for the entrance to active site and bicarbonate binding pocket.[10]

Activation by bicarbonate (HCO3) and calcium (Ca2+)

The binding and cyclizing of adenosine 5’ triphosphate (ATP) to the catalytic active site of the enzyme is coordinated by two metal cations. The catalytic activity of sAC is increase by the presence of manganese [Mn2+]. sAC magnesium [Mg2+] activity is regulated by calcium [Ca2+] which increases the affinity for ATP of mammalian sAC. In addition, bicarbonate [HCO3] releases ATP-Mg2+ substrate inhibition and increases Vmax of the enzyme.[11]

The open conformation state of sAC is reached when ATP, with Ca2+ bound to its γ-phosphate binds with specific residues in the catalytic center of the enzyme. When the second metal – a Mg2+ ion – binds to the α-phosphate of ATP leads to a conformational change of the enzyme: the close state. The change in conformation from open to close state induces esterification of the α-phosphate with the ribose in adenosine and the release of the β- and γ-phosphates, this leads to cyclizing.[6] Hydrogencarbonate stimulates the enzyme’s Vmax by promoting the allosteric change that leads to active site closure, recruitment of the catalytic Mg2+ ion, and readjustment of the phosphates in the bound ATP.[12] The activator bicarbonate binds to a site pseudo-symmetric to the active site and triggers conformational changes by recruiting Arg176 from the active site (see above - "structure").[10] Calcium increases substrate affinity by replacing the magnesium in the ion B site, which provides an anchoring point for the beta- and gamma-phosphates of the ATP substrate.[10][12]

Sources of bicarbonate (HCO3)and calcium (Ca2+)

Physiological effects

Brain and nervous system

Astrocytes express several sAC splice variants,[13] which are involved in metabolic coupling between neurons and astrocytes. Increase of potassium [K+] in the extracellular space caused by neuronal activity depolarizes the cell membrane of nearby astrocytes and facilitates the entry of hydrogencarbonate through Na+/HCO3- cotransporters.[6] The increase in cytosolic hydrogencarbonate activates sAC; the result of this activation is the release of lactate for use as energy source by the neurons.

Bone

Numerous sAC splice variants are present in osteoclast and osteoblasts,[2] and mutation in the human sAC gene is associated with low spinal density.[14] Calcification by osteoblasts is intrinsically related with hydrogencarbonate and calcium. Bone density experiments in mouse calvaria [15] cultured indicates that HCO3-sensing sAC is a physiological appropriate regulator of bone formation and/or reabsorption.

References

  1. 1 2 Williams, Simon; Farrell, Jeanne; Ramos, Lavoisier; et al. (2008). "Somatic 'soluble' adenylyl cyclase isoforms are unaffected in Sacytm1Lex /Sacytm1Lex 'knockout' mice". PLoS ONE. 3: e3251. doi:10.1371/journal.pone.0003251.
  2. 1 2 3 Geng, W; Wang, Z; Zhang, J (2005). "Cloning and characterization of the human soluble adenylyl cyclase". Am J Physiol Cell Physiol. 288: C1305–C1316. doi:10.1152/ajpcell.00584.2004.
  3. Schmid, A; Sutto, Z; Nlend, MC (2007). "Soluble adenylyl cyclase is localized to cilia and contributes to ciliary beat frequency regulation via production of cAMP". J Gen Physiol. 130: 99–109. doi:10.1085/jgp.200709784. PMC 2154360Freely accessible. PMID 17591988.
  4. 1 2 Jaiswal, BS; Conti, M (2001). "Identification and functional analysis of splice variants of the germ cell soluble adenylyl cyclase". J Biol Chem. 276: 31698–31708. doi:10.1074/jbc.m011698200.
  5. 1 2 3 Steegborn, C (Dec 2014). "Structure, mechanism, and regulation of soluble adenylyl cyclases - similarities and differences to transmembrane adenylyl cyclases". Biochim Biophys Acta. 1842 (12 Pt B): 2535–47. doi:10.1016/j.bbadis.2014.08.012. PMID 25193033.
  6. 1 2 3 Tresguerres, M; Levin, LR; Buck, J (2011). "Intracellular cAMP signaling by soluble adenylyl cyclase". Kidney Int. 79: 1277–88. doi:10.1038/ki.2011.95. PMC 3105178Freely accessible. PMID 21490586.
  7. Chaloupka, JA; Bullock, SA; Iourgenko, V (2006). "Autoinhibitory regulation of soluble adenylyl cyclase". Mol Reprod Dev. 73: 361–368. doi:10.1002/mrd.20409.
  8. Middelhaufe, S; Leipelt, M; Levin, LR; Buck, J; Steegborn, C (Oct 2012). "Identification of a haem domain in human soluble adenylate cyclase". Biosci. Rep. 32 (5): 491–9. doi:10.1042/BSR20120051. PMID 22775536.
  9. 1 2 Buck, J; Sinclair, ML; Schapal, L (1999). "Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals". Proc Natl Acad Sci USA. 96: 79–84. doi:10.1073/pnas.96.1.79. PMC 15096Freely accessible. PMID 9874775.
  10. 1 2 3 4 Kleinboelting, S; Diaz, A; Moniot, S; van den Heuvel, J; Weyand, M; Levin, LR; Buck, J; Steegborn, C (Mar 2014). "Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate". Proc. Natl. Acad. Sci. USA. 111 (10): 3727–32. doi:10.1073/pnas.1322778111. PMID 24567411.
  11. Litvin, TN; Kamenetsky, M; Zarifyan, A (2003). "Kinetic properties of 'soluble' adenylyl cyclase. Synergism between calcium and bicarbonate". J Biol Chem. 278: 15922–15926. doi:10.1074/jbc.m212475200.
  12. 1 2 Steegborn, C; Litvin, TN; Levin, LR (2005). "Bicarbonate activation of adenylyl cyclase via promotion of catalytic active site closure and metal recruitment". Nat Struct Mol Biol. 12: 32–37. doi:10.1038/nsmb880.
  13. Choi, Hyun B.; Gordon, Grant R.J.; Zhou, Ning; Tai, Chao; Rungta, Ravi L.; Martinez, Jennifer; Milner, Teresa A.; Ryu, Jae K.; McLarnon, James G.; Tresguerres, Martin; Levin, Lonny R.; Buck, Jochen; MacVicar, Brian A. (2012). "Metabolic Communication between Astrocytes and Neurons via Bicarbonate-Responsive Soluble Adenylyl Cyclase". Neuron. 75 (6): 1094–1104. doi:10.1016/j.neuron.2012.08.032. ISSN 0896-6273.
  14. Reed, BY; Gitomer, WL; Heller, HJ (2002). "Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density". J Clin Endocrinol Metab. 87: 1476–1485. doi:10.1210/jc.87.4.1476. PMID 11932268.
  15. Geng, W; Hill, K; Zerwekh, JE (2009). "Inhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclase". J Cell Physiol. 220: 332–340. doi:10.1002/jcp.21767.

External links

  1. "Intracellular cAMP signaling by soluble adenylyl cyclase". Kidney Int. 79: 1277–88. 2011. doi:10.1038/ki.2011.95. PMC 3105178Freely accessible. PMID 21490586. 
  2. "Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor". Science. 289: 625–8. July 2000. doi:10.1126/science.289.5479.625. PMID 10915626. 
  3. "Structure, mechanism, and regulation of soluble adenylyl cyclases - similarities and differences to transmembrane adenylyl cyclases.". Biochim Biophys Acta. 1842: 2535–47. Dec 2014. doi:10.1016/j.bbadis.2014.08.012. PMID 25193033. 
This article is issued from Wikipedia - version of the 3/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.